Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And...

Published on 7 Nov 2024 on Benzinga · via AOL

On Thursday, Becton, Dickinson and Company (NYSE:BDX) reported fourth-quarter sales of $5.44...

Read the rest of the article

Start tracking your investments with Statfolio

Free Report) released its fiscal 2024 fourth-quarter financial report after the closing bell, wit...

Zacks 8 Nov 2024

Steris PLC's strategic acquisitions, such as the purchase of surgical instrumentation assets from...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

On Thursday, Becton, Dickinson and Company (NYSE:BDX) reported fourth-quarter sales of $5.44...

Benzinga · via Yahoo Finance 7 Nov 2024

BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all...

Zacks 7 Nov 2024

On Thursday, Becton, Dickinson and Company (NYSE:BDX) reported fourth-quarter sales of $5.44...

Benzinga · via AOL 7 Nov 2024

Free Report) , popularly known as BD, is scheduled to report fourth-quarter fiscal 2024 results o...

Zacks 4 Nov 2024

Free Report) is scheduled to report second-quarter fiscal 2025 results on Nov. 6, after market...

Zacks 4 Nov 2024

Irvine-headquartered Edwards Lifesciences has successfully completed the sale of its Critical Car...

Los Angeles Times 3 Nov 2024

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this...

Insider Monkey · via Yahoo Finance 3 Nov 2024

We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 2...

Insider Monkey · via Yahoo Finance 13 Oct 2024